EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pharmaceutical Methotrexate Formulation Exposure Alters Growth and Biofilm of Pseudomonas aeruginosa with Exploratory Evidence for Folate-Pathway Involvement

Ohoud S. Alhumaidan, Abdulaziz A. Alfulaij, Rhodanne Nicole A. Lambarte, Terrence S. Sumague, Abdurahman A. Niazy

Life · 17.11.2026 · 16 (11) · 1942

DOI: 10.3390/life16111942 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Life, online erschienen am 17.11.2026. Verfasst von Ohoud S. Alhumaidan und 4 weiteren Autor:innen. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: King Saud University, Riyadh, Saudi Arabia.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pseudomonas aeruginosa remains challenging to control because of intrinsic antimicrobial resistance and biofilm-associated tolerance, highlighting the need to explore alternative therapeutic strategies. This study investigated the in vitro effects of a pharmaceutical methotrexate (MTX) formulation on P. aeruginosa PAO1, its interaction with gentamicin (GEN), and the potential relevance of selected folate-pathway proteins. Planktonic growth inhibition, growth kinetics, developing and preformed biofilm biomass, and biofilm-associated membrane integrity were evaluated. MTX-GEN interactions were evaluated by checkerboard analysis, while comparative molecular docking of MTX, fluorofolin, and trimethoprim against FolA, FolC, FolD, and ThyA was complemented by STRING/KEGG network analysis. Exposure to the MTX formulation produced concentration-dependent growth suppression, reaching the predefined GI80 at 75 mg/mL (165.04 mM), corresponding to 82.83% growth inhibition. Lower concentrations altered attached biofilm biomass and membrane-integrity profiles. Global MTX-GEN interaction scores fell within the additive/indifferent range, while selected combinations showed sustained growth suppression and biofilm-associated responses. Exploratory molecular docking predicted potential MTX binding configurations within the four modeled folate-pathway proteins, while functional-network analysis highlighted functional associations involving folate-dependent one-carbon metabolism. Together, these findings provide an integrated experimental and computational characterization of PAO1 responses to pharmaceutical MTX formulation exposure and identify folate-associated metabolic processes as a focused direction for further mechanistic investigation.

Förderung

  • King Saud University, Riyadh, Saudi Arabia

Zitieren

APA

Alhumaidan, O. S., Alfulaij, A. A., Lambarte, R. N. A., Sumague, T. S., & Niazy, A. A. (2026). Pharmaceutical Methotrexate Formulation Exposure Alters Growth and Biofilm of Pseudomonas aeruginosa with Exploratory Evidence for Folate-Pathway Involvement. Life, 16(11), 1942. https://doi.org/10.3390/life16111942

Vancouver

Alhumaidan OS, Alfulaij AA, Lambarte RNA, Sumague TS, Niazy AA. Pharmaceutical Methotrexate Formulation Exposure Alters Growth and Biofilm of Pseudomonas aeruginosa with Exploratory Evidence for Folate-Pathway Involvement. Life. 2026;16(11):1942. doi:10.3390/life16111942

BibTeX
@article{Alhumaidan2026,
  author = {Alhumaidan, Ohoud S. and Alfulaij, Abdulaziz A. and Lambarte, Rhodanne Nicole A. and Sumague, Terrence S. and Niazy, Abdurahman A.},
  title = {Pharmaceutical Methotrexate Formulation Exposure Alters Growth and Biofilm of Pseudomonas aeruginosa with Exploratory Evidence for Folate-Pathway Involvement},
  journal = {Life},
  year = {2026},
  volume = {16},
  number = {11},
  pages = {1942},
  doi = {10.3390/life16111942}
}
Kostenlos starten →